• Janssen Biotech Inc., of Spring House, Pa., part of Johnson & Johnson, of New Brunswick, N.J., and Johnson & Johnson Innovation established a research alliance with the Icahn School of Medicine at Mount Sinai to advance the scientific understanding of inflammatory bowel disease and the discovery of next-generation therapeutic solutions.